Skip to content

Second dose bookings available Monday to priority populations

As of Monday, May 17, anyone who is 85 and older or anyone who received their first dose before February 15 will be eligible to book their second doses.
vaccine

As of Monday, May 17, anyone who is 85 and older or anyone who received their first dose before February 15 will be eligible to book their second doses. Individuals diagnosed with or being treated for cancer and those who have received solid organ transplants will receive a letter of eligibility in the mail that will allow them to access a second dose.

For all other residents, your eligibility to book for second doses will be announced according to the age-based and priority sequencing of first doses. 

Note that the SHA online patient booking system will be able to make booked clinic appointments for second doses starting at 8am, Tuesday, May 18.  Starting Monday, May 17, second dose vaccinations will be available at participating pharmacies across the province, through the Saskatchewan Health Authority (SHA) drive-thru and walk-in clinics as well as through clinics operated by Indigenous Services Canada and the Northern Inter-tribal Health Authority (NITHA). 

Be ready by knowing the date you received your first vaccine.  If you do not know the date or have misplaced the wallet card provided at the time of your first dose, call 1-833-SaskVax (1-833-727-5829) and they can provide you with that date, or check your Immunization History on your MySaskHealthRecord account.

During your second dose appointment, the clinic or pharmacy will validate the timing and brand of your first dose to ensure you are receiving your second dose within the recommended timeframe.  The type of vaccine available at each location will be advertised to ensure that you are receiving the same vaccine brand for your second dose.

At this time, public health is planning to offer your second dose of COVID-19 vaccine to match the brand of your first dose.  National reviews of the safety and efficacy of interchanging the second dose brand are on-going and the provincial policy on maintaining the same brand for the second dose may be updated following this review.